Florida Cancer Center

Sarasota, Florida 34232

0 studies enrolling now · 3 studies all time

What they study most

HER2-negative Breast Cancer, Hormone Receptor Positive Breast Carcinoma, Melanoma, Solid Tumors

Studies at this site

• A Dose Escalation/Expansion Study of Oral OP-1250 in Subjects With Advanced and/or Metastatic HR+, HER2- Breast Cancer — Completed
• Study of Trametinib and Nab-paclitaxel in Patients With Melanoma — Withdrawn before enrolling
• Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors — Completed